Collagen matrix staple line reinforcement in gastric bypass.
BACKGROUND
Staple line leaks and bleeding, anastomotic strictures, and marginal ulcers are significant complications of Roux-en-Y gastric bypass (RYGB) for morbid obesity. Reinforcing the staple lines with bovine collagen matrix reinforcement (CMR) might safely decrease the incidence of leaks and bleeding without causing other complications. Our objective was to determine the effect in RYGB of reinforcing the linear and circular gastric staple lines with CMR on the outcomes including abdominal septic events, blood transfusions, and the incidence of stricture and marginal ulceration of the gastrojejunostomy in a private bariatric surgery practice at 2 Surgical Review Committee Center of Excellence community hospitals.


METHODS
We performed a retrospective review of prospectively collected data comparing consecutive outcomes of 505 patients undergoing RYGB without CMR from 2005 to 2006 to 568 patients with CMR of the linear and circular gastric staple lines from 2007 to 2009.


RESULTS
The application of CMR was associated with a significant reduction from 4% to 1% in the incidence of abdominal septic events, including frank staple line leakage, purulent drainage, and abscess. The number of patients needing transfusion showed a trend downward. The frequency of stricture (1%) and marginal ulceration (2%) was unchanged. No gastrogastric fistulas were identified in either group. No evidence of migration of collagen matrix material appeared after CMR. The 90-day mortality rate for each group was .2% and was unrelated to staple line complications.


CONCLUSIONS
The use of CMR was associated with a significant reduction in the incidence of abdominal septic complications and a trend toward fewer patients needing transfusion. The frequency of stricture and marginal ulceration was unchanged by the use of CMR.
Pomerado Hospital, Poway, California, USA. c.callery1@gmail.com
Charles D
CD
Callery
Sam
S
Filiciotto
Kelly L
KL
Neil
D000328:Adult; D057868:Anastomotic Leak / Q000517:prevention & control; D003094:Collagen / Q000627:therapeutic use*; D003251:Constriction, Pathologic / Q000517:prevention & control; D004868:Equipment Failure; D005260:Female; D015390:Gastric Bypass / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D059413:Intraabdominal Infections / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D019106:Postoperative Hemorrhage / Q000517:prevention & control; D011446:Prospective Studies; D012189:Retrospective Studies; D018805:Sepsis / Q000517:prevention & control; D017792:Surgical Stapling / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome
D003094:Collagen